Small molecule inhibitors of hepatitis C virus
US9174988B2 · kind B2 · utility
2Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 27, 2010 |
| Grant date | Nov 3, 2015 |
| Priority date | — |
| Expiry date | Mar 11, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides derivatives and analogs of triazatetracyclo[7.7.0.01,13.02,7]-hexadeca-2,4,6,10,12-pentaenes, 5,7,11-triazatetracyclo[8.7.0.01,6.012,17]-heptadeca-6,8,12,14,16-pentaenes, pharmaceutical compositions comprising these compounds and methods for treatment of hepatitis C viral infections using these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.